AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of tumor marker oncology

Results: 26-50/191

Authors: Nisman, B Heching, N Barak, V
Citation: B. Nisman et al., Serum tumor markers in resectable and non-resectable non-small cell lung cancer, J TUMOR M, 15(3), 2000, pp. 195-207

Authors: Klein, A
Citation: A. Klein, Cytokeratin 20 as a potential tumor marker, J TUMOR M, 15(3), 2000, pp. 209-213

Authors: Hirschberg, L Bezzegh, A Aronsson, AC
Citation: L. Hirschberg et al., LIAISON (R) TPA, the automated chemiluminescence immunoassay for the determination of cytokeratins 8, 18 and 19, J TUMOR M, 15(3), 2000, pp. 215-217

Authors: Birkmayer, GD
Citation: Gd. Birkmayer, Resumee of the 17th International Conference on Human Tumor Markers - HongKong, March 23-24 2000, J TUMOR M, 15(2), 2000, pp. 105-107

Authors: Birkmayer, GD
Citation: Gd. Birkmayer, Resumee of the International Symposium on Tumor Markers and Cancer Treatment, Guangzhou, March 24-26, 2000, J TUMOR M, 15(2), 2000, pp. 109-109

Authors: Dnistrian, AM Schwartz, MK Smith, CA Schwartz, DC
Citation: Am. Dnistrian et al., Clinical evaluation of the CA 15-3 (TM) assay on the sayer immune 1 (TM) system, J TUMOR M, 15(2), 2000, pp. 111-116

Authors: Li, CH Zhang, LX Lu, YF
Citation: Ch. Li et al., RIA of plasma GST-pi and its diagnostic significance in breast tumor, J TUMOR M, 15(2), 2000, pp. 117-122

Authors: Zhang, SL Schinella, R
Citation: Sl. Zhang et R. Schinella, Expressions of ER, PR, Her2/neu and Ki-67 and their correlation in 55 cases of infiltrating ductal carcinoma of the breast, J TUMOR M, 15(2), 2000, pp. 123-127

Authors: Goussia, AC Ioachim, EE Agnantis, NJ Zagorianakou, P Vougiouklakis, T Tsianos, EV Kappas, A
Citation: Ac. Goussia et al., Expression of cell adhesion molecule CD44 in human gastric cancer. A correlation with P53 and Rb proteins, the HLA-DR antigen and the proliferative activity, J TUMOR M, 15(2), 2000, pp. 129-137

Authors: Xu, M Zhang, JR Li, P
Citation: M. Xu et al., The molecular mechanisms of nicotinamide adenine dinucleotide in inhibiting human liver cells from apoptosis induced by cisplatin, J TUMOR M, 15(2), 2000, pp. 139-145

Authors: Heisele, O Ferdats, A Engele, L
Citation: O. Heisele et al., Melanoma associated antigens as additional markers of tumor progression, J TUMOR M, 15(2), 2000, pp. 147-153

Citation: 17(th) International Conference on Human Tumor Markers - March 23-24, 2000- Hong Kong SAR, China - Abstracts, J TUMOR M, 15(1), 2000, pp. 14

Authors: Sun, M Yang, C Yin, L Shupe, T Ilic, Z Fridreich, T Sell, D
Citation: M. Sun et al., Preliminary microarray analysis of differences in mRNAs of cell cycle control and carcinogen metabolizing enzymes in normal and p53 null mice, J TUMOR M, 15(1), 2000, pp. 77-84

Authors: Birrer, R Nasr, H Klavins, JV
Citation: R. Birrer et al., Alphafetoprotein: The role of receptor binding sites, J TUMOR M, 15(1), 2000, pp. 85-92

Authors: Birrer, RB Nasr, H Klavins, JV
Citation: Rb. Birrer et al., Alphafetoprotein (AFP) and its Antibodies, J TUMOR M, 15(1), 2000, pp. 93-98

Authors: Klavins, JV
Citation: Jv. Klavins, A personal note - Professor George@Birkmayer, J TUMOR M, 15(1), 2000, pp. 99-99

Authors: Banfalvi, T Gilde, K Bezzegh, A Schumann, B Fejos, Z Liszkay, G Otto, S
Citation: T. Banfalvi et al., Clinical significance of S-100 protein assay in malignant melanoma, J TUMOR M, 14(4), 1999, pp. 5-12

Authors: Simickova, M Pecen, L Cernoch, M Vagunda, V Pochmon, D Vermousek, I Lang, B Pacovsky, Z
Citation: M. Simickova et al., Prognostic significance of c-erbB-2 (HER-2/neu) oncoprotein in benign and malignant breast tumor tissue, J TUMOR M, 14(4), 1999, pp. 13-22

Authors: Florianczyk, B Grzybowska, L
Citation: B. Florianczyk et L. Grzybowska, Metallothionein and zinc level in breast cancer, J TUMOR M, 14(4), 1999, pp. 23-27

Authors: Stern, P Friedecky, B
Citation: P. Stern et B. Friedecky, Reliability of the immunoassay measurement of tumor markers, J TUMOR M, 14(4), 1999, pp. 29-36

Authors: Birrer, RB Nasr, H Klavins, JV
Citation: Rb. Birrer et al., Alphafetoprotein levels in health and disease states, J TUMOR M, 14(4), 1999, pp. 37-44

Authors: Moniem, H Choi, YJ Niedt, W
Citation: H. Moniem et al., Expression of Ki-67, PCNA, p-53, and HMB-45 in melanocytic lesions, J TUMOR M, 14(3), 1999, pp. 11-17

Authors: Chen, YJ Lo, KY Tzen, CY Huang, RD Chang, KH Lai, YL Chung, CH Chen, ML
Citation: Yj. Chen et al., Relationship of bcl-2 and pp125(FAK) expression to outcome of radiation therapy in prostate carcinoma, J TUMOR M, 14(3), 1999, pp. 19-24

Authors: Kusec, V Vrbanec, D Juricic, M Jusufhodzic, L Belev, B Unusic, J
Citation: V. Kusec et al., Evidence of increased bone turnover in breast cancer patients with bone metastases in a retrospective study, J TUMOR M, 14(3), 1999, pp. 25-33

Authors: Yasasever, V Meral, R Camlica, H Duranyildiz, D Dalay, N
Citation: V. Yasasever et al., Serum NSE levels in the Turkish population, J TUMOR M, 14(3), 1999, pp. 35-40
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>